Search hospitals > North Carolina > Durham
Duke Eye Center
Claim this profileDurham, North Carolina 27701
Global Leader in Age-Related Macular Degeneration
Global Leader in Glaucoma
Conducts research for Retinal Disease
Conducts research for Macular Degeneration
Conducts research for Retinitis Pigmentosa
108 reported clinical trials
15 medical researchers
Summary
Duke Eye Center is a medical facility located in Durham, North Carolina. This center is recognized for care of Age-Related Macular Degeneration, Glaucoma, Retinal Disease, Macular Degeneration, Retinitis Pigmentosa and other specialties. Duke Eye Center is involved with conducting 108 clinical trials across 121 conditions. There are 15 research doctors associated with this hospital, such as Lejla Vajzovic, MD, Sharon F Freedman, MD, Cynthia A Toth, MD, and Ramiro Maldonado, MD.Area of expertise
1Age-Related Macular Degeneration
Global LeaderStage I
Stage II
CFI rare variant positive
2Glaucoma
Global LeaderTop PIs
Lejla Vajzovic, MDDuke Eye Center1 year of reported clinical research
Studies Retinal Disease
Studies Retinitis Pigmentosa
7 reported clinical trials
8 drugs studied
Sharon F Freedman, MDDuke University Eye Center3 years of reported clinical research
Studies Retinal Disease
Studies Preterm Birth
5 reported clinical trials
5 drugs studied
Cynthia A Toth, MDDuke University Eye Center8 years of reported clinical research
Studies Retinal Disease
Studies Preterm Birth
5 reported clinical trials
6 drugs studied
Ramiro Maldonado, MDDuke Eye Center1 year of reported clinical research
Studies Age-Related Macular Degeneration
Studies Stargardt Disease
3 reported clinical trials
2 drugs studied
Clinical Trials running at Duke Eye Center
Age-Related Macular Degeneration
Lazy Eye
Retinopathy of Prematurity
Glaucoma
Macular Degeneration
Retinal Disease
Retinal Detachment
Cystoid Macular Edema
Edema
Diabetic Macular Edema
SUSVIMO
for Age-Related Macular Degeneration
This study will assess corneal endothelial cells in participants with nAMD treated with PDS refilled every 24 weeks (Q24W).
Recruiting3 awards Phase 410 criteria
RGX-314 Gene Therapy
for Age-Related Macular Degeneration
This trial is testing a new one-time gene therapy called RGX-314 for patients with wet AMD. The goal is to reduce the need for regular treatments by helping the eye produce its own protective proteins. This could make treatment easier and more effective for patients.
Recruiting2 awards Phase 32 criteria
4D-150 + EYLEA
for Age-Related Macular Degeneration
A Phase 3, Randomized, Double-Masked, Active-Controlled Trial in Adults with Macular Neovascularization Secondary to Age-Related Macular Degeneration
Recruiting2 awards Phase 34 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Duke Eye Center?
Duke Eye Center is a medical facility located in Durham, North Carolina. This center is recognized for care of Age-Related Macular Degeneration, Glaucoma, Retinal Disease, Macular Degeneration, Retinitis Pigmentosa and other specialties. Duke Eye Center is involved with conducting 108 clinical trials across 121 conditions. There are 15 research doctors associated with this hospital, such as Lejla Vajzovic, MD, Sharon F Freedman, MD, Cynthia A Toth, MD, and Ramiro Maldonado, MD.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.